The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
暂无分享,去创建一个
P. Neven | G. Sledge | S. Johnston | X. Pivot | Kenichi Inoue | N. Masuda | A. Llombart-Cussac | E. Grischke | P. Conte | P. Kaufman | M. Toi | J. Sohn | K. Hurt | H. Koh | S. Barriga | M. Okera | O. Burdaeva | Martin Frenzel | Yi Lu